abstract |
The invention concerns nucleic acid and amino acid sequences of variants of TNF-receptor obtained by alternative splicing. The invention also concerns expression vectors, host cells, pharmaceutical compositions, and detection assays making use of these sequences, as well as antibodies reactive with the sequences. |